Nichols Weston's Form 4 filing
TScan Therapeutics, Inc. (TCRX) · filed Dec 16, 2024
- Accession no.
- 0000902664-24-006934
- Filed
- Dec 16, 2024, 4:26 PM ET
- Trade date
- Dec 12-13, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $385.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nichols WestonCIK 0001746376 | 10% Owner |
| Lynx1 Capital Management LPCIK 0001910456 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2024 | Common stock, $0.0001 par value per share ("Common Stock") | PPurchaseAcquired | +31,800 | $3.01 | +$95,628.96 | 5,257,347 | Indirect | |
| Dec 13, 2024 | Common Stock | PPurchaseAcquired | +100,000 | $2.90 | +$290,140 | 5,357,347 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.